Skip to main content

Chemosensitivity tests in colorectal cancer patients

Abstract

In order to assess the usefulness of chemosensitivity tests in the treatment of colorectal cancer, 71 tumor specimens were tested for chemosensitivity in the following assays: nude mouse isotope assay (NMIA), subrenal capsule assay (SRCA), human tumor clonogenic assay (HTCA) and adenosine triphosphate inhibition assay (ATPA). The agents examined were: mitomycin C (MMC), 5-fluorouracil (5-FU), cyclophosphamide (CPM), adriamycin (ADM) and cis-diamminedichloroplatinum (CDDP). The evaluability rates were 90.8, 93.9 and 92.3 per cent in NMIA, SRCA and ATPA, respectively, but only 42.9 per cent in HTCA. The tumor response rates were 50.8, 45.2, 16.7 and 33.3 per cent in NMIA, SRCA, HTCA and ATPA, respectively. Individual drug sensitivity rates differed among all 4 assays, ranging from 0 to 33.3 per cent. In the arbitrary judgment of the 4 assays, the most sensitive agent was CDDP, followed by CPM, ADM, 5-FU and MMC. In the prospective study, predictive accuracy rates of the clinical responses were 81.3 66.7, 100, 100 and 76.5 per cent in NMIA, SRCA, HTCA, ATPA and the arbitrary judgment, respectively. A significant correlation between the survival time and the results of SRCA was detected retrospectively. These results suggested that colorectal cancer might not be completely resistant to anticancer agents, and that chemosensitivity tests might be useful in the individual therapy of colorectal cancer patients.

This is a preview of subscription content, access via your institution.

References

  1. Lawrence W, Terz JJ, Horsley S, Donaldson M, Lovett WL, Brown PW, Ruffnen BW, Regelson W. Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg 1978; 181: 616–622.

    Article  Google Scholar 

  2. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: Demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospective controlled, randomized trial. Surg Clin North Am 1981; 61: 1321–1329.

    PubMed  CAS  Google Scholar 

  3. Higgins GA, Amadeo JH, McElhinney J, McCaughan JJ, Keehn RJ. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl-CCNU following resection for carcinoma of the large bowel. A veterans administration surgical oncology group report. Cancer 1984; 53: 1–8.

    PubMed  Article  Google Scholar 

  4. Hamburger AE, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977; 197: 641–663.

    Google Scholar 

  5. Bogden AE, Cobb WR, Lepage DJ, Haskell PM, Gulkin TA, Ward A, Kelton DE, Esber HJ. Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mice: Six-day subrenal capsule assay. Cancer 1981; 48: 10–20.

    PubMed  CAS  Article  Google Scholar 

  6. Tani T, Nishimawari K, Noso Y, Hattori T. Chemosensitivity test. In: Shimosato S, Tamaki K, eds. Human cancer and nude mouse. Tokyo: Ishiyaku shuppan 1982; 287–294. (in Japanese)

    Google Scholar 

  7. Noso Y, Niimi K, Nishiyama M, Hirabayashi N, Toge T, Niimoto M, Hattori T. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation. Cancer Res 1984; 47: 6418–6422.

    Google Scholar 

  8. Hirabayashi N, Noso Y, Niimi K, Nishiyama M, Yamaguchi M, Toge T, Niimoto M, Hattori T, Comparative studies onin vitro human tumor clonogenic assay (HTCA) andin vivo nude mouseisotope assay (NM-IA). Jpn J Surg 1987; 17: 104–109.

    PubMed  CAS  Article  Google Scholar 

  9. Nishiyama M, Noso Y, Yamaguchi M, Hirabayashi N, Toge T, Niimoto M, Hattori T. Comparative study on nude mice isotope assay (NM-IA) and subrenal capsule assay (SRCA) sensitivity tests of anticancer agents. Jpn J Surg 1987; 17: 99–103.

    PubMed  CAS  Article  Google Scholar 

  10. Nishiyama M, Noso Y, Yamaguchi M, Hirabayashi N, Toge T, Niimoto M, hattori T. Prediction of individual tumor chemosensitivity in subrenal capsule assay. Jpn J Surg 1986; 16: 257–261.

    PubMed  CAS  Article  Google Scholar 

  11. Von Hoff DD, Casper J, Bradley E, Standbach J, Jones D, Mukuch R. Association between human tumor colony-forming assay results and response of an individual patient’s tumor to chemotherapy. Am J Med 1981; 70: 1027–1032.

    Article  Google Scholar 

  12. Kangas L, Gronroos M, Nieminen AL. Bioluminescence of cellular ATP: A new method for evaluating cytotoxic agentsin vitro. Medical Biology 1984; 62: 338–343.

    PubMed  CAS  Google Scholar 

  13. Koyama Y. Criteria of Japan Society for Cancer Therapy. Jpn J Cancer Chemotherapy 1986; 13: 391–396.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Yanagawa, E., Nishiyama, M., Saeki, T. et al. Chemosensitivity tests in colorectal cancer patients. The Japanese Journal of Surgery 19, 432–438 (1989). https://doi.org/10.1007/BF02471624

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02471624

Key Words

  • chemosensitivity test
  • nude mouse isotope assay
  • subrenal capsule assay
  • human tumor clonogenic assay
  • adenosine triphosphate inhibition assay